210 related articles for article (PubMed ID: 28944846)
1. Hedyotis diffusa Willd suppresses metastasis in 5‑fluorouracil‑resistant colorectal cancer cells by regulating the TGF‑β signaling pathway.
Lai Z; Yan Z; Chen W; Peng J; Feng J; Li Q; Jin Y; Lin J
Mol Med Rep; 2017 Nov; 16(5):7752-7758. PubMed ID: 28944846
[TBL] [Abstract][Full Text] [Related]
2. Hedyotis diffusa Willd inhibits proliferation and induces apoptosis of 5‑FU resistant colorectal cancer cells by regulating the PI3K/AKT signaling pathway.
Li Q; Lai Z; Yan Z; Peng J; Jin Y; Wei L; Lin J
Mol Med Rep; 2018 Jan; 17(1):358-365. PubMed ID: 29115462
[TBL] [Abstract][Full Text] [Related]
3. The anti-tumor effect and bioactive phytochemicals of Hedyotis diffusa willd on ovarian cancer cells.
Zhang L; Zhang J; Qi B; Jiang G; Liu J; Zhang P; Ma Y; Li W
J Ethnopharmacol; 2016 Nov; 192():132-139. PubMed ID: 27426510
[TBL] [Abstract][Full Text] [Related]
4. Investigating the Multi-Target Pharmacological Mechanism of
Song Y; Wang H; Pan Y; Liu T
Biomolecules; 2019 Oct; 9(10):. PubMed ID: 31600936
[No Abstract] [Full Text] [Related]
5. Water extract of Hedyotis Diffusa Willd suppresses proliferation of human HepG2 cells and potentiates the anticancer efficacy of low-dose 5-fluorouracil by inhibiting the CDK2-E2F1 pathway.
Chen XZ; Cao ZY; Chen TS; Zhang YQ; Liu ZZ; Su YT; Liao LM; Du J
Oncol Rep; 2012 Aug; 28(2):742-8. PubMed ID: 22641337
[TBL] [Abstract][Full Text] [Related]
6. Hedyotis diffusa Willd extract suppresses Sonic hedgehog signaling leading to the inhibition of colorectal cancer angiogenesis.
Lin J; Wei L; Shen A; Cai Q; Xu W; Li H; Zhan Y; Hong Z; Peng J
Int J Oncol; 2013 Feb; 42(2):651-6. PubMed ID: 23291612
[TBL] [Abstract][Full Text] [Related]
7. Hedyotis diffusa Willd. inhibits VEGF‑C‑mediated lymphangiogenesis in colorectal cancer via multiple signaling pathways.
Li H; Lai Z; Yang H; Peng J; Chen Y; Lin J
Oncol Rep; 2019 Sep; 42(3):1225-1236. PubMed ID: 31322263
[TBL] [Abstract][Full Text] [Related]
8. Baicalein inhibits migration and invasion of gastric cancer cells through suppression of the TGF-β signaling pathway.
Chen F; Zhuang M; Peng J; Wang X; Huang T; Li S; Lin M; Lin H; Xu Y; Li J; Chen Z; Huang Y
Mol Med Rep; 2014 Oct; 10(4):1999-2003. PubMed ID: 25109410
[TBL] [Abstract][Full Text] [Related]
9. Knockdown of long non‑coding RNA PVT1 reverses multidrug resistance in colorectal cancer cells.
Fan H; Zhu JH; Yao XQ
Mol Med Rep; 2018 Jun; 17(6):8309-8315. PubMed ID: 29693171
[TBL] [Abstract][Full Text] [Related]
10. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
[TBL] [Abstract][Full Text] [Related]
11. MEGF6 Promotes the Epithelial-to-Mesenchymal Transition via the TGFβ/SMAD Signaling Pathway in Colorectal Cancer Metastasis.
Hu H; Wang M; Wang H; Liu Z; Guan X; Yang R; Huang R; Tang Q; Zou C; Wang G; Gao X; Wang X
Cell Physiol Biochem; 2018; 46(5):1895-1906. PubMed ID: 29719292
[TBL] [Abstract][Full Text] [Related]
12. Valproic acid inhibits epithelial‑mesenchymal transition in renal cell carcinoma by decreasing SMAD4 expression.
Mao S; Lu G; Lan X; Yuan C; Jiang W; Chen Y; Jin X; Xia Q
Mol Med Rep; 2017 Nov; 16(5):6190-6199. PubMed ID: 28901475
[TBL] [Abstract][Full Text] [Related]
13. Systems pharmacology uncover the mechanism of anti-non-small cell lung cancer for Hedyotis diffusa Willd.
Su X; Li Y; Jiang M; Zhu J; Zheng C; Chen X; Zhou J; Li Y; Xiao W; Wang Y
Biomed Pharmacother; 2019 Jan; 109():969-984. PubMed ID: 30551551
[TBL] [Abstract][Full Text] [Related]
14. Effect of Smad3/4 on chemotherapeutic drug sensitivity in colorectal cancer cells.
Moon SU; Kang MH; Sung JH; Kim JW; Lee JO; Kim YJ; Lee KW; Bang SM; Lee JS; Kim JH
Oncol Rep; 2015 Jan; 33(1):185-92. PubMed ID: 25370208
[TBL] [Abstract][Full Text] [Related]
15. Antitumor potential of Hedyotis diffusa Willd: A systematic review of bioactive constituents and underlying molecular mechanisms.
Han X; Zhang X; Wang Q; Wang L; Yu S
Biomed Pharmacother; 2020 Oct; 130():110735. PubMed ID: 34321173
[TBL] [Abstract][Full Text] [Related]
16.
Li Q; Wang X; Shen A; Zhang Y; Chen Y; Sferra TJ; Lin J; Peng J
Exp Ther Med; 2015 Nov; 10(5):1845-1850. PubMed ID: 26640560
[TBL] [Abstract][Full Text] [Related]
17. Exploring the mechanisms of anti-ovarian cancer of Hedyotis diffusa Willd and Scutellaria barbata D. Don through focal adhesion pathway.
Xu X; Chen F; Zhang L; Liu L; Zhang C; Zhang Z; Li W
J Ethnopharmacol; 2021 Oct; 279():114343. PubMed ID: 34147618
[TBL] [Abstract][Full Text] [Related]
18. Hedyotis diffusa Willd inhibits colorectal cancer growth in vivo via inhibition of STAT3 signaling pathway.
Cai Q; Lin J; Wei L; Zhang L; Wang L; Zhan Y; Zeng J; Xu W; Shen A; Hong Z; Peng J
Int J Mol Sci; 2012; 13(5):6117-6128. PubMed ID: 22754353
[TBL] [Abstract][Full Text] [Related]
19. miR-34a mediates oxaliplatin resistance of colorectal cancer cells by inhibiting macroautophagy
Sun C; Wang FJ; Zhang HG; Xu XZ; Jia RC; Yao L; Qiao PF
World J Gastroenterol; 2017 Mar; 23(10):1816-1827. PubMed ID: 28348487
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of Therapeutic Mechanism of Hedyotis Diffusa Willd (HDW)‒ Scutellaria Barbata (SB) in Clear Cell Renal Cell Carcinoma
Bai Y; Chen R; Sun J; Guo Y
Comb Chem High Throughput Screen; 2024; 27(6):910-921. PubMed ID: 37526191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]